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ABSTRACT
DNA methylation profiling has become an important
aspect of biomedical molecular analysis. Polymerase
chain reaction (PCR) amplification of bisulphite-
treated DNA is a processing step that is common
to many currently used methods of quantitative
methylation analysis. Preferential amplification of
unmethylated alleles—known as PCR-bias—may
significantly affect the accuracy of quantification.
To date, no universal experimental approach has
been reported to overcome the problem. This
study presents an effective method of correcting
biased methylation data. The procedure includes a
calibration performed in parallel to the analysis of
the samples under investigation. DNA samples with
defined degrees of methylation are analysed. The
observed deviation of the experimental results
from the expected values is used for calculating a
regression curve. The equation of the best-fitting
curve is then used for correction of the data obtained
from the samples of interest. The process can be
applied irrespective of the locus interrogated and
the number of sites analysed, avoiding an opti-
mization of the amplification conditions for each
individual locus.
INTRODUCTION
Quantiﬁcation of changes in DNA methylation is becom-
ing increasingly important in biomedical and particularly
cancer research, since epigenetic biomarkers have a
considerable potential for diagnostics (1). Several
methods are in use to analyse DNA methylation patterns
(2), ranging from measurements at individual CpG di-
nucleotides (3–5) to large-scale and genome-wide appro-
aches by next-generation sequencing (6) or hybridization
to DNA microarrays (7,8). Many analysis techniques are
based on the common step of treating the DNA with
bisulphite. Sodium bisulphite converts unmethylated
cytosine to uracil, which turns into thymine upon poly-
merase chain reaction (PCR) ampliﬁcation. In contrast,
methylated cytosines remain unaffected. The C-T conver-
sion can be picked up by any method of DNA sequence
determination. For sensitivity reasons, an ampliﬁcation
step is required subsequent to the bisulphite treatment.
Since the actual measurement occurs on the amplicon
and not the original DNA, the accuracy of the PCR step
strongly inﬂuences the accuracy of the analysis.
PCR ampliﬁcation of bisulphite-treated DNA often
results in a selective enrichment of unmethylated
alleles—a phenomenon known as PCR-bias (9)—and
may therefore reﬂect the real situation incorrectly.
Preferential recovery of methylated forms is also possible
although less common. The extent of such deviations is
difﬁcult to predict, however. Several studies addressed the
experimental conditions in order to enable unbiased amp-
liﬁcation. One approach suggests the use of specially de-
signed PCR primers (10,11), which should contain CpG
dinucleotides (usually 1 or 2). This is meant to facilitate
primer binding to the methylated allele and could thus
avoid disproportional ampliﬁcation. An alternative strat-
egy aims at inhibiting the formation of secondary struc-
tures by GC-rich and methylated regions, which is
considered to be the reason of biased ampliﬁcation, by
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PCR cycles (12). Finally, the use of single-molecule PCR
has been proposed (13). It eliminates bias because there is
no competition between DNA templates that are
ampliﬁed with different efﬁciencies.
The reported processes for avoiding PCR-bias rely on a
careful optimization of PCR conditions and their effect-
iveness remains contradictory (14). Although shown to be
effective for particular genes, their implementation is time
consuming and labour intensive, especially if multiple loci
are analysed. A method for obtaining unbiased DNA
methylation data irrespective of the locus under investi-
gation would therefore be advantageous. In contrast to
the approaches mentioned above, we suggest not to
avoid PCR-bias by laborious optimization of the experi-
mental conditions but to correct appropriately the results
obtained after ampliﬁcation. The procedure established to
achieve this end includes a calibration performed on DNA
samples with deﬁned degrees of methylation in parallel to
the analysis of the samples under investigation. The
observed deviation from the expected results is then ap-
plied for correcting the data obtained from the samples of
interest.
MATERIALS AND METHODS
Calibration DNA
Fully methylated and unmethylated human control DNA
that was bisulphite-treated (EpiTect PCR control DNA;
Qiagen, Hilden, Germany) was mixed in different ratios to
obtain calibration samples that represent distinct methy-
lation percentages of 0%, 12.5%, 25%, 37.5%, 50%,
62.5%, 75%, 87.5% and 100%, respectively. An addition-
al calibration DNA of 6.25% methylation was included to
the study of the SFRP1 promoter because of the extreme
bias observed for amplifying methylated DNA. The fully
methylated calibration DNA was produced by the manu-
facturer using SssI methylase. Unmethylated DNA was
generated by means of whole-genome ampliﬁcation.
According to the manufacturer’s information, the fully
methylated control is completely methylated at all CpG
sites and can be used irrespective of the locus analysed.
This could be veriﬁed for sites that are cleaved by restric-
tion enzymes, whose activity depends on the methylation
status. Concordantly, full methylation of different loci has
been reported by independent studies, which employed
this commercial control DNA (15–17).
PCR ampliﬁcation
PCR was carried out in 25-ml reactions of 1.5ml EpiTect
control DNA (10ng/ml), 1.5mM MgCl2, 125mM dNTP,
200nM primers, 0.65U HotStarTaq DNA polymerase
and 1x Q-solution (Qiagen). An ampliﬁcation programme
was used that had been described previously (18) with
minor modiﬁcation. It was started by an initial activation
of the HotStarTaq DNA polymerase at 95 C for 15min.
The initial ampliﬁcation cycle was denaturation at 95 C
for 1min, annealing at 62 C for 2min and elongation
at 72 C for 3min. This procedure was continued for
20 cycles, reducing the annealing temperature by 0.5 C
each cycle, followed by 25 cycles of 1min denaturation
at 95 C, 2min annealing at 52 C and 2min elongation
at 72 C. The sequences of the PCR primers used are
listed in Table 1. Three separate PCR reactions were per-
formed for the ampliﬁcation of each region of interest.
About 5ml of each reaction was examined on 2%
agarose gels.
Bisulphite pyrosequencing
A volume of 20-ml PCR product was added to 2ml
Streptavidin Sepharose High Performance (GE Healthcare,
Uppsala, Sweden), 38ml of PyroMark binding buffer
(Qiagen) and 20ml water and mixed. The Vacuum Prep
Workstation (Biotage, Uppsala, Sweden) was used to
prepare single-stranded DNA according to the manufac-
turer’s instructions. The Sepharose beads with the single-
stranded templates attached were released into a PSQ 96
Plate Low (Biotage) containing 15ml of 0.6mM corres-
ponding sequencing primer in annealing buffer.
Pyrosequencing reactions were performed using the Pyro
Gold Reagent Kit (Biotage) in a PSQ HS 96
Pyrosequencing System (Biotage) according to the manu-
facturer’s protocol. Quantiﬁcation of CpG site methyla-
tion was performed with the Software PyroQ-CpG v.1.0.9
(Biotage). The sequences of the pyrosequencing primers
are listed in Table 1.
Bisulphite sequencing
The PCR-ampliﬁed region of DKK2 was subcloned using
the TOPO TA cloning kit for sequencing (Invitrogen,
Carlsbad, USA). Ten clones were picked at random and
sequenced using Sanger chemistry by GATC (Constance,
Germany). A representation of the sequencing data was
made using the CpGviewer software (19).
Isolation and bisulphite conversion of DNA from cell lines
and CD19
+ B cells of healthy individuals
The chronic lymphocytic leukaemia cell lines MEC-1 (20)
and EHEB (21) were grown in a medium consisting of
90% Iscove’s Modiﬁed Dulbecco’s Medium (Invitrogen)
or Roswell Park Memorial Institute Medium (Invitrogen),
respectively, supplemented with 10% fetal bovine serum
(Invitrogen). CD19
+ B cells (22) were isolated from the
buffy coats of ﬁve healthy individuals provided by the
Institute for Clinical Transfusion Medicine and Cell
Therapy (Heidelberg, Germany) using Dynabeads CD19
pan B (Invitrogen). DNA was extracted using the
QIAamp DNA Blood Mini kit (Qiagen). DNA concentra-
tion was measured in a ND-1000 spectrophotometer
(Thermo Scientiﬁc, Wilmington, USA). A total of 1.9mg
DNA was treated with sodium bisulﬁte using the EpiTect
Bisulﬁte kit (Qiagen). The efﬁciency of bisulphite conver-
sion averaged 98.8% and was computed from the se-
quences of 63 cloned PCR products of CDH1, DACT1,
DKK1, DKK2, DKK3, DKK4, SFRP2 (8 clones each) and
SFRP3 (seven clones) using the BISMA software (23),
which considers the non-CpG cytosines within the se-
quences. Subsequently, 2ml of bisulphite-converted DNA
was used for PCR ampliﬁcation.
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Ampliﬁcation of different DNA regions is biased to a
different extent
For initial analyses, calibration DNA was used. Fully
methylated and unmethylated DNA was mixed to create
samples of a deﬁned methylation status. After bisulphite
treatment and PCR ampliﬁcation, pyrosequencing was
applied to quantify the apparent degree of methylation.
CpG dinucleotides were studied that are located in prox-
imity of the transcriptional start sites of 10 human genes
(Table 1). The candidate genes were selected randomly but
for the fact that they are known to be epigenetically
silenced in a variety of human cancers. We plotted the
apparent percentage of methylation determined in the
DNA amplicons produced from the calibration DNA
(y-axis) as a function of the actual methylation degree
(x-axis) (Figure 1). The ampliﬁcation step introduced
bias of a different degree to the 10 fragments. There was
practically unbiased ampliﬁcation of DKK3 and SFRP3,
a moderate bias towards the unmethylated alleles for
CDH1, DACT1, DKK1, DKK2, DKK4, PYGO2 and
SFRP2 as well as an extreme deviation towards the
methylated allele for SFRP1. The unusual last result
might be explained as the use of a PCR primer that con-
tained a single CpG dinucleotide and had been described
in an earlier study (24) for compensating biased ampliﬁ-
cation of the unmethylated DNA, although an inﬂuence of
the amplicon sequence cannot be excluded either.
As a quantitative measure of PCR-bias, the value b was
used (Figure 1) as suggested by Warnecke et al. (9). This
factor reﬂects the difference between the observed and
actual degree of methylation and is derived from the
equation of a hyperbolic best-ﬁt curve:
y ¼
100bx
ðbx   x+100Þ
ð1Þ
Balanced recovery of methylated and unmethylated alleles
during ampliﬁcation can be described with b=1. Using
b=1 in Equation (1) leads to a linear function (y=x).
Preferential PCR ampliﬁcation of unmethylated alleles is
described by 0<b<1 and a concave curve (Figure 1),
whereas a more uncommon accumulation of methylated
DNA is reﬂected by b>1 and a convex curve (e.g. the
SFRP1 gene in Figure 1). The value b reﬂects the efﬁciency
of primer binding and polymerase elongation in amplicons
derived from unmethylated or methylated DNA. Owing to
sequence differences after bisulphite conversion, DNA
may adopt distinct secondary structures or exhibit a
different melting behaviour, which lead to ampliﬁcation
bias (9).
Table 1. Sequences of the PCR and pyrosequencing primers used in this study
Gene
symbol
Primer sequences Amplicon
length, bp
No. of CpGs quantiﬁed
by pyrosequencing/total
no. in amplicon
CDH1 F: 50-TTTTTTTTGATTTTAGGTTTTAGTGAG-30 421 9/33
R: 50-bio-ACTCCAAAAACCCATAACTAACC-30
S: 50-AGTTAGTTTAGATTTTAGTT-30
DACT1 F: 50-GTTTGGGAAGTGAAAGAAATTTAATT-30 184 5/12
R: 50-bio-CTAAAACCCCAACATCCTATTACAAT-30
S: 50-AGATTGTGTTGTAATTTGGT-30
DKK1 F: 50-bio-GGGGTGAAGAGTGTTAAAGGTT-30 326 8/18
R: 50-AAACCATCATCTCAAAAAAACTCAA-30
S: 50-CTACAAAAAACACAAAACTCTAC-30
DKK2 F: 50-bio-TTTTAGTAGTTGTGGGTGGAGATA-30 456 11/27
R: 50-ATACTCCTTTTCAAAATTAACAAAC-30
S: 50-CCTAACTCACAAAAAACAAC-30
DKK3 F: 50-GATTTTGTTGAGTTTAGTTTTTTTTGGT-30 123 5/5
R: 50-bio-CAAACCTCTCTCAACCCCTACCTA-30
S: 50-TTTTTTGGTGGATGTG-30
DKK4 F: 50-bio-ATAGATTTGAAGGGATTTGTTGAAGTTT-30 328 2/11
R: 50-CAAAACCAACTCAACCCCAACAAAAC-30
S: 50-CTAAACTAACAACTCAACAC-30
PYGO2 F: 50-TGAGATTTAGAGAGGTTATTTAAGT-30 252 9/22
R: 50-ACATATAAAAATCCAAATTCCCC-30
S: 50-GGTATTTTATAGATAGGTGT-30
SFRP1 F: 50-GTTTTGTTTTTTAAGGGGTGTTGAG-30 412 8/25
R: 50-bio-CTCCGAAAACTACAAAACTAAAATAC-30
S: 50-TYGGGAGTTGATTGG-30
SFRP2 F: 50-ATGTTTGGTAATTTAGTAGAAATTT-30 409 14/30
R: 50-bio-CAACCAAAATTTTCTTAACCTTTTT-30
S: 50-GATTGGGGTAAAATAAGTT-30
SFRP3 F: 50-bio-GTGATTTAGGGGAGGAGATATTTTAGA-30 542 4/29
R: 50-TTCCAAAACAAAAACTTACACAAAA-30
S: 50-CAAAATAAAACAAAATACAAC-30
F, PCR forward; R, PCR reverse; S, pyrosequencing.
PAGE 3 OF 12 Nucleic Acids Research,2011, Vol.39, No. 11 e77Figure 1. Degree of bias introduced by PCR ampliﬁcation of 10 gene promoters from calibration DNAs. To compute a numeric value of PCR-bias,
the apparent degree of methylation observed after ampliﬁcation (y-axis) was plotted as a function of the actual methylation percentage (x-axis). Each
value represents the average of three measurements. By regression analyses (red lines), the value b was calculated as described in the text. It reﬂects
the difference between the actual and the measured degree of methylation. The dotted lines represent an unbiased plot (b=1). In each panel, the
equation of the best-ﬁt curve is shown.
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in order to describe more adequately the data obtained
from bisulphite pyrosequencing. The ampliﬁcation of
DNA of 0% or 100% methylation cannot be biased
because there is no competition between methylated and
unmethylated DNA templates. Nevertheless, differences
between actual and apparent methylation of the respective
calibration samples were observed. For the 10 gene loci
studied, the average differences were 5% methylation
instead of 0% and 89% rather than the actual 100%.
These differences are the result of an additional bias
introduced by the pyrosequencing and base-calling pro-
cess. By including the data points obtained from samples
with 0% and 100% methylation into the curve-ﬁtting
calculation, this additional bias was corrected, too. In
order to ﬁnd the family of hyperbolic curves, which pass
through the extreme calibration points with abscissae of
x=0 and x=100, a generalization of the above equation
was used [see Supplementary Data for derivation of
Equation (2)]:
y ¼
½ðby1   y0Þx+100 
ðbx   x+100Þ
ð2Þ
The terms y0 and y1 represent the apparent methylation
degree of DNA with 0% and 100% methylation, respect-
ively. Equation (2) is of the same type as Equation (1) and
can be transformed to it by setting y0=0 and y1=100.
Based on Equation (2), values of b were computed from
the experimental data by minimizing the sum of squared
errors as described (25). Application of Equation (2) was
superior to that of Equation (1), leading to a signiﬁcant
decrease of the sum of squared errors (data not shown).
The results of the ampliﬁcation of each of the 10 loci in the
calibration DNA could be described by such a ﬁtted curve
(Figure 1).
Correction of biased methylation values
Having demonstrated biased ampliﬁcation for most genes
of our set, we addressed the question, if the error could be
eliminated effectively by taking advantage of the equa-
tions of the best-ﬁt curves. Correction was done for each
control sample by expressing the unknown x (the actual
methylation degrees) and solving the algebraic equations
substituting the variable y with the apparent methylation
percentages obtained in the experiment:
x ¼
ð100y0   100yÞ
ðby   by1+y0   yÞ
ð3Þ
This led to a signiﬁcant improvement of the measure-
ment accuracy and a substantial decrease of relative
error (Table 2). The process was particularly effective
for DNA samples of 37.5% methylation and higher. The
effect was much less pronounced for low methylation
degrees. For example, the 25% methylation control sample
in genes DACT1, DKK1, SFRP2 and PYGO2 exhibited
relative errors of 16%, 23%, 30% and 20%, respectively.
Although relatively high, the corrected values produced
still less error than the raw data. In consequence, we won-
dered if an even better regression solution may exist that
would be superior to hyperbolic regression at low methy-
lation but still of the same quality at higher values, and
thus could be applied universally.
Applying the criterion of minimizing the sum of squared
errors (Table 2), cubic polynomial ﬁt curves were found to
improve substantially the correction results at 25% methy-
lation (Figure 2). The following equation was used for
curve ﬁtting:
y ¼ ax3+cx2+dx+e ð4Þ
where a, c, d and e are arbitrary parameters. The ﬁtting
was performed followed by solving the cubic equations for
the unknown x with Cardano’s method described else-
where (26). Typical reductions of the relative errors were
from 30% (hyperbolic) to 13% (cubic polynomial) for
SFRP2 (Figure 2) and 23% (hyperbolic) to 7% (cubic
polynomial) for DKK1, for example. Also, cubic polyno-
mial ﬁt curves could be applied generally, achieving at
least the effectiveness of correction obtained with the
hyperbolic ﬁt curves (Table 2, Figure 3). The only excep-
tion was the gene SFRP1; due to the enormous bias
towards the methylated allele, better correction effective-
ness was achieved by using hyperbolic regression, which
accommodated more readily the deﬁned 0% and 100%
values.
Table 2. Comparison of PCR-bias correction results using two types of regression curves
Gene symbol Numeric value of PCR-bias (b) Average relative errows (%) Sum of squared errors
Raw Hyperbolic Polynomial Raw Hyperbolic Polynomial Hyperbolic Polynomial
CDH1 0.58 (1.72-fold) 1.01 0.97 21 2 3 41.0 36.6
DACT1 0.83 (1.20-fold) 1.02 0.99 10 7 4 86.4 28.0
DKK1 0.63 (1.59-fold) 1.04 0.99 17 4 2 32.6 4.9
DKK2 0.67 (1.49-fold) 1.03 1.00 20 2 3 23.5 8.4
DKK3 0.93 (1.08-fold) 1.00 0.98 11 4 5 45.7 40.0
DKK4 0.69 (1.45-fold) 1.33 0.95 18 2 4 5.1 4.5
PYGO2 0.69 (1.45-fold) 0.99 0.97 25 6 5 36.32 31.8
SFRP1 22.04 (22.04-fold) 1.38 0.25 158 18 35 36.03 383.6
SFRP2 0.47 (2.13-fold) 1.06 0.95 28 6 4 49.6 32.8
SFRP3 0.93 (1.08-fold) 1.00 0.97 7 5 6 51.9 47.8
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The PCR-bias correction described so far was based on
nine calibration samples. For simplifying the correction
process, we examined if the number of controls could be
reduced while still providing consistent correction power.
Using the ﬁt curves based on only ﬁve (0%, 25%, 50%,
75% and 100% methylation), four (0%, 25%, 75% and
100%) or three (0%, 50% and 100%) calibration samples,
we investigated if we were able accurately to predict
methylation degrees for the calibration samples of
37.5%, 62.5% and 87.5% methylation, using the genes
with the largest bias (SFRP2, CDH1, DKK1 and DKK2).
The corrected values were very similar by using down to
three calibration samples (Figure 4). No major difference
was observed in average relative errors compared to using
nine calibration samples (Supplementary Figure S1).
Accuracy of correction does not depend on the degree of
PCR-bias
Correction of PCR-bias is only of use if the accuracy of
correction is not affected by its degree. In order to test
this, DNA fragments with differently biased PCR
ampliﬁcation yields were artiﬁcially produced of the
same loci. Preferential ampliﬁcation of unmethylated
alleles is thought to be due to a dissimilar ability of
unmethylated and methylated DNA to form secondary
structures (9). Therefore, we hypothesized that a PCR
additive, which modiﬁes the melting behaviour of DNA
should affect the extent of PCR-bias at least in some cases.
Q-solution of Qiagen has such an effect and was actually
routinely used for ampliﬁcation reactions in this study.
For four genes—DACT1, DKK2, DKK3 and DKK4—we
produced PCR products without the additive. This
affected negatively the value of PCR-bias for DACT1 (b
value 0.57 instead of 0.83) and DKK3 (0.68 versus 0.93),
had a minor inﬂuence on DKK2 (0.56 versus 0.66) and did
not inﬂuence ampliﬁcation of DKK4 (0.71 versus 0.71).
However, the values obtained after correction using ﬁve
calibration DNA samples were very similar irrespective of
the numeric value of initial PCR-bias (Table 3).
Correcting methylation measurements in leukaemic cell
lines MEC-1 and EHEB and CD19
+ B cells from
healthy individuals
As an example of PCR-bias correction with a DNA from
a biological sample, we analysed in the chronic lympho-
cytic leukaemia cell line MEC-1 (20) the methylation of 11
CpG dinucleotides located in close proximity to the DKK2
transcriptional start site. Bisulphite-treated DNA was
analysed by pyrosequencing as well as Sanger sequencing.
Figure 2. Typical results of bias correction. The experimental methylation results obtained from the promoter region of the SFRP2 gene were
corrected using a cubic polynomial ﬁt curve. The blue bars represent raw data; the red bars show the corrected values. The actual methylation
degrees were 25, 37.5, 50, 62.5, 75, 87.5 and 100%. In addition to each methylation percentage value, also the relative error is shown.
e77 Nucleic Acids Research, 2011,Vol. 39,No. 11 PAGE 6 OF 12Figure 3. The result of PCR-bias correction by means of cubic polynomial regression. The corrected methylation degree (y-axis) is plotted as a
function of the actual percentage of methylation (x-axis) for the set of genes analysed (for comparison see Figure 1). The red lines represent the
corrected plots. The essentially linear function of y(x) and the fact that the values of b are close to 1 demonstrate effective elimination of PCR-bias
from the experimental data. The data of the SFRP1 gene were corrected using hyperbolic regression (see text for details).
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subcloned PCR products were analysed (Figure 5a). The
raw data derived from both sequencing methods were in
remarkably good agreement (Figure 5b), which might be
explained by a relatively heterogeneous methylation
pattern of the region. In parallel, an analysis of calibration
DNA was performed. Using this information, the methy-
lation values for each of the 11 CpG dinucleotides had to
be corrected (Figure 5c), indicating the frequency of
biased results if DNA from natural sources is being
studied. The absolute value of the difference between cor-
rected and uncorrected data differs among sites. As can be
inferred from the regression curves (Figure 1), the differ-
ence between ascertained (uncorrected) and actual methy-
lation values depends on the absolute percentage of
methylation. The difference should be minimal at either
hypo- or hypermethylated CpGs and reach a maximum
for intermediate methylation levels (around 50% methy-
lation). This could be the reason for smaller differences
between the corrected and uncorrected values at CpG sites
Figure 4. Inﬂuence of the number of calibration samples on the accuracy of bias correction. An analysis which was corrected on the basis of only
ﬁve (0, 25, 50, 75 and 100% methylation), four (0, 25, 75 and 100%) or three (0, 50 and 100%) DNA samples resulted in essentially similarly correct
data. The blue bars represent the raw data; the bars of different shades of red show the corrected values. In addition to each methylation percentage
value, also the relative error is indicated. The actual methylation percentages are listed at the bottom.
Table 3. Accuracy of bias correction does not depend on its degree
Actual
methylation (%)
Raw and corrected methylation values (%)
DACT1 DKK2 DKK3
+Q-sol.  Q-sol. +Q-sol.  Q-sol. +Q-sol.  Q-sol.
raw corr. raw corr. raw corr. raw corr. raw corr. raw corr.
04 0 5 0 7 0 1 2 0 2 0 5 0
25 27 25 22 25 23 25 28 22 21 24 23 23
50 45 49 36 50 38 50 39 55 48 52 41 54
75 66 74 54 75 57 75 48 73 68 74 55 74
100 94 98 87 100 85 100 80 100 89 100 87 100
e77 Nucleic Acids Research, 2011,Vol. 39,No. 11 PAGE 8 OF 12Figure 5. Correction of the DKK2 methylation degree in leukaemic cell line MEC-1 using cubic polynomial regression. (a) CpG map of the
interrogated region (top). Vertical bars indicate the positions of CpG dinucleotides. The position of the ﬁrst exon is shown as a black rectangle.
The arrow indicates the DKK2 transcriptional start site. The red bar (denoted ‘PYRO’) speciﬁes the CpG sites quantiﬁed by pyrosequencing; the blue
bar (marked ‘BS SEQ’) indicates the region analysed by Sanger sequencing. In the DNA methylation patterns shown below, each row of circles
(continued)
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bias introduced by the pyrosequencing readout may also
happen and lead to the unexpectedly high difference at
CpG 6, for example.
As an additional illustration of PCR-bias correction,
methylation degrees of CDH1, DACT1, DKK1, DKK2,
DKK3, DKK4, SFRP2 and SFRP3 were quantiﬁed in
the leukaemic cell lines MEC-1 and EHEB as well as
CD19
+ B cells from healthy individuals (Supplementary
Figure S2). Most of the loci were aberrantly hyper-
methylated in both cell lines, whereas essentially no
methylation was observed in the CD19
+ B cells, with
few exceptions. Also in this experiment, the methylation
percentages had to be corrected for nearly every gene. As
expected, the differences between the apparent and cor-
rected methylation levels were more pronounced for
those genes, which exhibited a higher degree of PCR-
bias (Table 2) and a higher percentage of methylation
(for example, CDH1, DKK1 and DKK2).
DISCUSSION
The occurrence of PCR-bias in DNA methylation studies,
which are based on bisulphite treatment, and the lack of
processes to predict its extent ask for the development of
correction procedures in order to produce accurate data,
since erroneous measurements may strongly hamper the
interpretation of the results. To date, no universally ap-
plicable solution had been reported to overcome the
problem.
In most cases analysed, an over-ampliﬁcation of the
unmethylated alleles was observed; this is in agreement
with earlier reports interrogating other loci (9,10,12).
Interestingly, ampliﬁcation of SFRP1 demonstrated an
inverse and rather large (22-fold) deviation towards the
methylated allele. In consequence, ampliﬁcation of
genomic DNA of only 6.25% and 12.5% real methylation
already yielded a strongly exaggerated experimental result
of 51% and 70%, respectively. This deviation could be
explained by the presence of a CpG dinucleotide at the
50-end of the reverse PCR primer used for ampliﬁcation.
Rather than balancing ampliﬁcation bias, the presence of
the CpG site in the primer sequence may have led to over-
compensation, thereby introducing an inverse bias. This
observation is important in the context of recent reports
(10,11,14), which propose the use of this primer design
scheme for a more unbiased ampliﬁcation of bisulphite-
treated DNA on a routine basis. Although the approach
could be effective for particular genes, wider applicability
may be hampered by effects such as demonstrated for the
biased ampliﬁcation of SFRP1. However, earlier studies
(e.g. 9) have also reported a few other examples of
preferential enrichment of methylated alleles. While the
presence of CpGs in the primer-annealing sites could be
a factor which causes PCR-bias of the methylated allele,
also other reasons may be possible. In any case, each
primer pair needs to be checked to assure its effectiveness.
In this context, non-CpG methylation as found in em-
bryonic cells (27,28) represents a special case and possibly
a challenge to both PCR-primer design and calibration-
based correction. For primer design, the number of
non-CpG cytosines in the sequences should be limited in
order to avoid binding variation, although their effect
should be less pronounced compared to CpGs, because
the latter inﬂuence DNA structure stronger. If a possibly
methylated cytosine within the primer sequence cannot be
avoided, a mismatch to both the methylated and unmethy-
lated sequence should be incorporated into the primer at
the respective position as has been suggested for CpG
dinucleotides (29). For calibration, the problem arises on
how the actual degree of methylation in the calibration
samples could be conﬁrmed.
As opposed to reﬁning experimental conditions, we ap-
proached the correction of ampliﬁcation bias by accepting
its occurrence during experimentation but adjusting the
initial ampliﬁcation result by a comparison to calibration
data and the application of regression curves for deriving
correction factors. Two types of regression—hyperbolic
and cubic polynomial—were applied. The correction
process based on cubic polynomial regression was found
to be superior overall. A reason for this could be the fact
that the experimental background noise contributes max-
imally to the uncorrected data if the signal intensities
(for both unmethylated and methylated alleles) are low.
Interestingly, the methylation values for a 50% methyla-
tion control (the point of minimal background inﬂuence)
belong to both the hyperbolic and cubic ﬁt curves for all
the genes.
The method is applicable irrespective of the locus that is
interrogated or the number of sites analysed. Based on
curve ﬁtting, the method is not inﬂuenced by the type of
bias–preferential recovery of methylated or unmethylated
alleles—and works equally well for both as documented
by SFRP1. Furthermore, any bias that was additionally
introduced by the pyrosequencing readout could be
compensated by the very process. The method is also
automatable for high-throughput analyses.
On the down side of the method, concomitant measure-
ments of at least three calibration DNA samples are
required. However, given the fact that no optimization of
the reagents is needed, such as the use of modiﬁed primers
for example, and that sequencing technologies are cur-
rently rapidly getting cheaper and higher in throughput,
this fact should not be a limiting factor in the long run.
Figure 5. Continued
represents the CpG dinucleotides of an individual clone sequence. The open and ﬁlled circles stand for unmethylated and methylated CpGs,
respectively. The pyrogram at the bottom indicates the methylation degrees of 11 CpG dinucleotides in proximity of the DKK2 transcriptional
start site. Grey bars highlight the signals corresponding to CpG sites analysed. The percent values above the pyrogram reﬂect the methylation degree
determined for each CpG site. The sequence of nucleotides at the bottom is the dispensation order of the dNTPs during the pyrosequencing process.
The lower panel provides the corresponding conformation for CD19
+B cells of a healthy individual. (b) A scatterplot comparison of the methylation
degree of each of the 11 CpGs as determined by Sanger sequencing (vertical axis) and pyrosequencing (horizontal axis). (c) The diagram shows
uncorrected (blue) and corrected (cubic polynomial regression with nine control DNA samples; red) methylation values of the CpG sites.
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quantitative DNA methylation analysis may beneﬁt.
Obviously, the relative monetary and time effect of our
correction method in comparison to conventional
protocol-optimizing approaches depends on the scale
(number of loci), throughput (number of test samples)
and the particular analytical technique that is applied.
For a bisulphite pyrosequencing analysis of one locus in
96 patients, for example, the regression algorithm is
estimated to save about 80% of time and actual cost,
while losing only 3 out of 96 wells and thus samples
(3%) to calibration.
The situation is similar in more high-throughput
approaches based on microarray analysis (30) or mas-
sively parallel bisulphite sequencing (31). The latter pub-
lication, for instance, describes a DNA methylation
analysis of 12 ampliﬁed loci from 69 breast cancer
samples. The resulting 828 PCR products were tagged
with sample-speciﬁc sequences, pooled and sequenced
with a depth of coverage of 880 reads per amplicon and
sample. Inclusion of three calibration samples to the pools
would increase the number of ampliﬁcation reactions by
about 4.5% (36 in addition to 828) and reduce the
sequence coverage per amplicon and sample insigniﬁcantly
to about 840 instead of 880. The only cost increase would
be an extra 4.5% for PCR, while sequencing cost would
not be affected.
Finally, for genome-wide analyses, there is actually no
feasible alternative to the calibration approach. For
instance, when a sequencing library is prepared by frag-
mentation of genomic DNA using a cocktail of restriction
enzymes (32), one could not reasonably perform with
current technology an optimisation of the ampliﬁcation
conditions for all possible methylation sites of the
genome. Genome-wide calibration, however, can be
done. Admittedly, this would require the sequencing of
three calibration genome copies, while only one sequence
would represent the real epigenetic status of the respective
genome. However, no alternative exists to get exact data.
In addition, the calibration sequences can be used for all
additional genome sequences. Still, accurate proﬁling of
DNA methylation does come at a cost.
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